As of 2025-09-15, the EV/EBITDA ratio of Precision BioSciences Inc (DTIL) is -0.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DTIL's latest enterprise value is 14.46 mil USD. DTIL's TTM EBITDA according to its financial statements is -76.98 mil USD. Dividing these 2 quantities gives us the above DTIL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 13.0x | 10.8x |
| Forward P/E multiples | 11.8x - 19.2x | 15.5x |
| Fair Price | (52.11) - 7.19 | (30.17) |
| Upside | -1230.4% - 56.0% | -754.5% |
| Date | EV/EBITDA |
| 2025-09-10 | -0.25 |
| 2025-09-09 | -0.26 |
| 2025-09-08 | -0.24 |
| 2025-09-05 | -0.26 |
| 2025-09-04 | -0.25 |
| 2025-09-03 | -0.26 |
| 2025-09-02 | -0.25 |
| 2025-08-29 | -0.23 |
| 2025-08-28 | -0.25 |
| 2025-08-27 | -0.25 |
| 2025-08-26 | -0.25 |
| 2025-08-25 | -0.27 |
| 2025-08-22 | -0.24 |
| 2025-08-21 | -0.21 |
| 2025-08-20 | -0.20 |
| 2025-08-19 | -0.22 |
| 2025-08-18 | -0.24 |
| 2025-08-15 | -0.20 |
| 2025-08-14 | -0.21 |
| 2025-08-13 | -0.20 |
| 2025-08-12 | -0.15 |
| 2025-08-11 | -0.15 |
| 2025-08-08 | -0.15 |
| 2025-08-07 | -0.18 |
| 2025-08-06 | -0.22 |
| 2025-08-05 | -0.23 |
| 2025-08-04 | -0.22 |
| 2025-08-01 | -0.19 |
| 2025-07-31 | -0.21 |
| 2025-07-30 | -0.22 |
| 2025-07-29 | -0.23 |
| 2025-07-28 | -0.26 |
| 2025-07-25 | -0.27 |
| 2025-07-24 | -0.25 |
| 2025-07-23 | -0.24 |
| 2025-07-22 | -0.23 |
| 2025-07-21 | -0.19 |
| 2025-07-18 | -0.19 |
| 2025-07-17 | -0.19 |
| 2025-07-16 | -0.17 |
| 2025-07-15 | -0.16 |
| 2025-07-14 | -0.19 |
| 2025-07-11 | -0.16 |
| 2025-07-10 | -0.22 |
| 2025-07-09 | -0.21 |
| 2025-07-08 | -0.17 |
| 2025-07-07 | -0.14 |
| 2025-07-03 | -0.15 |
| 2025-07-02 | -0.13 |
| 2025-07-01 | -0.11 |